Current studies focusing on these novel peptides, a unique type of agents showing significant potential for affecting multiple condition processes. Distinct from conventional small molecule techniques, Nexaph chains offer enhanced targeting and lesser unintended reactions, allowing them a truly attractive option for future medicinal innovation. Ong